Intrinsic Value

Immunovant, Inc. (IMVT)

$28.8

+0.19 (+0.66%)

Enterprise Value -
Net Debt -375.31
Equity Value -
Shares Outstanding 123.08
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt